Articles | Volume 6, issue 9
https://doi.org/10.5194/jbji-6-413-2021
https://doi.org/10.5194/jbji-6-413-2021
Original full-length article
 | 
12 Nov 2021
Original full-length article |  | 12 Nov 2021

Mid-term clinical results of chronic cavitary long bone osteomyelitis treatment using S53P4 bioactive glass: a multi-center study

Tom A. G. Van Vugt, Jeffrey Heidotting, Jacobus J. Arts, Joris J. W. Ploegmakers, Paul C. Jutte, and Jan A. P. Geurts

Related authors

Wound drainage after arthroplasty and prediction of acute prosthetic joint infection: prospective data from a multicentre cohort study using a telemonitoring app
Henk Scheper, Rachid Mahdad, Brenda Elzer, Claudia Löwik, Wierd Zijlstra, Taco Gosens, Joris C. T. van der Lugt, Robert J. P. van der Wal, Rudolf W. Poolman, Matthijs P. Somford, Paul C. Jutte, Pieter K. Bos, Richard E. Zwaan, Rob G. H. H. Nelissen, Leo G. Visser, Mark G. J. de Boer, and the wound care app study group
J. Bone Joint Infect., 8, 59–70, https://doi.org/10.5194/jbji-8-59-2023,https://doi.org/10.5194/jbji-8-59-2023, 2023
Short summary
First evaluation of a commercial multiplex PCR panel for rapid detection of pathogens associated with acute joint infections
Jorrit Willem Adriaan Schoenmakers, Rosanne de Boer, Lilli Gard, Greetje Anna Kampinga, Marleen van Oosten, Jan Maarten van Dijl, Paulus Christiaan Jutte, and Marjan Wouthuyzen-Bakker
J. Bone Joint Infect., 8, 45–50, https://doi.org/10.5194/jbji-8-45-2023,https://doi.org/10.5194/jbji-8-45-2023, 2023
Short summary
Nuclear imaging does not have clear added value in patients with low a priori chance of periprosthetic joint infection. A retrospective single-center experience
Karsten D. Ottink, Stefan J. Gelderman, Marjan Wouthuyzen-Bakker, Joris J. W. Ploegmakers, Andor W. J. M. Glaudemans, and Paul C. Jutte
J. Bone Joint Infect., 7, 1–9, https://doi.org/10.5194/jbji-7-1-2022,https://doi.org/10.5194/jbji-7-1-2022, 2022
Short summary

Related subject area

Subject: Bone substitutes | Topic: All topics
Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions – a single center experience
Eva Steinhausen, Rolf Lefering, Martin Glombitza, Nikolaus Brinkmann, Carsten Vogel, Bastian Mester, and Marcel Dudda
J. Bone Joint Infect., 6, 73–83, https://doi.org/10.5194/jbji-6-73-2021,https://doi.org/10.5194/jbji-6-73-2021, 2021
Short summary

Cited articles

Blaha, J. D., Calhoun, J. H., Nelson, C. L., Henry, S. L., Seligson, D., Esterhai, J. L., Jr., Heppenstall, R. B., Mader, J., Evans, R. P., and Wilkins, J.: Comparison of the clinical efficacy and tolerance of gentamicin PMMA beads on surgical wire versus combined and systemic therapy for osteomyelitis, Clin. Orthop. Relat. Res., 295, 8–12, 1993. 
Bortolin, M., De Vecchi, E., Romano, C. L., Toscano, M., Mattina, R., and Drago, L.: Antibiofilm agents against MDR bacterial strains: is bioactive glass BAG-S53P4 also effective?, J. Antimicrob. Chemother., 71, 123–127, https://doi.org/10.1093/jac/dkv327, 2016. 
Cierny III, G., Mader, J. T., and Penninck, J. J.: A clinical staging system for adult osteomyelitis, Clin. Orthop. Relat. Res., 414, 7–24, https://doi.org/10.1097/01.blo.0000088564.81746.62, 2003. 
Coraca-Huber, D. C., Fille, M., Hausdorfer, J., Putzer, D., and Nogler, M.: Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms grown on titanium discs in vitro, J. Orthop. Res., 32, 175–177, https://doi.org/10.1002/jor.22463, 2014. 
Detsch, R., Stoor, P., Grunewald, A., Roether, J. A., Lindfors, N. C., and Boccaccini, A. R.: Increase in VEGF secretion from human fibroblast cells by bioactive glass S53P4 to stimulate angiogenesis in bone, J. Biomed. Mater. Res. A, 102, 4055–4061, https://doi.org/10.1002/jbm.a.35069, 2014. 
Download
Short summary
Chronic osteomyelitis is a bone infection and was treated with a combination of antibiotics and two surgeries. With the introduction of the biomaterial S53P4 bioactive glass, these infections can be treated with antibiotics and one surgery. This study shows 85 % success in the treatment of these bone infections. Together with the fundamentally different antibacterial mechanisms without antibiotic resistance, S53P4 bioactive glass is recommendable for the treatment of these infections.